| DIRECT COMPETITOR COMPARISON | |
| BVF | LLY | NVS | TEVA | Industry | | Market Cap: | 2.24B | 42.40B | 125.78B | 46.59B | 74.33M | | Employees: | N/A | 40,500 | 99,000 | 38,307 | 43 | | Qtrly Rev Growth (yoy): | 17.40% | 6.80% | 2.40% | 24.90% | 3.00% | | Revenue (ttm): | 760.87M | 21.11B | 42.31B | 12.95B | 17.49M | | Gross Margin (ttm): | 71.90% | 82.33% | 72.61% | 55.30% | 63.53% | | EBITDA (ttm): | 359.76M | 7.74B | 11.24B | 3.94B | -6.12M | | Oper Margins (ttm): | 30.18% | 30.97% | 21.50% | 24.35% | -3.79% | | Net Income (ttm): | 223.84M | -216.00M | 7.59B | 953.00M | N/A | | EPS (ttm): | 1.413 | -0.197 | 3.34 | 1.093 | -0.19 | | P/E (ttm): | 10.01 | N/A | 16.58 | 48.38 | 15.29 | | PEG (5 yr expected): | 1.39 | 4 | 2.89 | 0.98 | 1.28 | | P/S (ttm): | 2.98 | 2.04 | 3.00 | 3.62 | 3.39 |
|
| LLY = Eli Lilly & Co. | | NVS = Novartis AG | | TEVA = Teva Pharmaceutical Industries Limited | | Industry = Drug Delivery | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.50 | -1.02% | 57.19B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.92 | -1.12% | 13.57B | 15.70 | | Genzyme Corp. | GENZ | 51.07 | -0.87% | 13.55B | 29.12 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.56 | -0.89% | 41.90B | 18.00 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.95 | -1.85% | 8.91B | 1019.39 | | Teva Pharmaceutical Industries Limited | TEVA | 52.88 | -0.53% | 46.59B | 48.38 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 36.96 | -2.25% | 3.92B | 19.05 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.95 | -1.08% | 2.97B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.01 | -1.53% | 5.50B | 110.49 | | Pfizer Inc. | PFE | 18.25 | -1.83% | 147.27B | 15.16 | | Johnson & Johnson | JNJ | 62.89 | -0.65% | 173.52B | 13.73 | | GlaxoSmithKline plc | GSK | 42.26 | -1.45% | 107.13B | 13.42 | | Sanofi-Aventis | SNY | 38.43 | -2.61% | 100.35B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.38 | -0.84% | 125.78B | 16.58 | | RHHBY.PK | 41.46 | -1.96% | N/A | N/A | | AstraZeneca plc | AZN | 45.29 | -2.35% | 65.67B | 9.09 | | Abbott Laboratories | ABT | 54.08 | -0.61% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.38 | -1.05% | 50.28B | 13.13 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | TEVA | | Israel Stocks: Israel stocks off; Osem up, Migdal off on reports
Sun 8:38am -
at MarketWatch | | • | NVS | | Increase In Patent Protection For Biologics Creates Significant Upside For Drug Development Enterprise Valuations
Sat 10:31am -
Wall Street Transcript | | • | LLY | | [$$] Jim Cramer's Best Blogs
Sat 8:54am -
at RealMoney by TheStreet.com | | • | LLY | | [$$] Glimmers in a Fading Year
Sat 8:03am -
at Barrons.com | | • | NVS | | A Fool Looks Back
Sat 8:03am -
at Motley Fool | | • | NVS | | Novartis says FDA approves Agriflu seasonal shot
Fri, Nov 27 -
AP | | • | LLY | | TradingMarkets 7 Stocks You Need to Know for Monday
Fri, Nov 27 -
TradingMarkets.com | | • | LLY | | Byetta Label Revised
Fri, Nov 27 -
Zacks.com | | • | LLY | | This Big Winner Has Hit Its Prime
Fri, Nov 27 -
at Motley Fool | | • | NVS | | 5-Star Stocks Poised to Pop: Diageo
Fri, Nov 27 -
at Motley Fool | | • | TEVA | | Sanofi Beats on Higher Revenue
Fri, Nov 27 -
Zacks.com | | • | LLY | | 5 Good Dividend Plays
Fri, Nov 27 -
at Seeking Alpha | | • | NVS | | Novartis Partners with U.S. Government for Faster Flu Vaccine Manufacturing
Thu, Nov 26 -
at Seeking Alpha | | • | NVS | | [$$] Charting the Market Wednesday
Wed, Nov 25 -
at Barrons.com | | • | LLY | | Sitting Atop An Earnings Powder Keg
Wed, Nov 25 -
at Forbes.com | | • | TEVA | | Turning to Widow and Orphan Stocks
Wed, Nov 25 -
at Barrons.com | | • | TEVA | | Build Your Fortune With These Winners
Wed, Nov 25 -
at Motley Fool | | • | TEVA | | Cephalon Settles Barr Challenge
Wed, Nov 25 -
Zacks.com | | • | TEVA | | Israel Stocks: Tel Aviv broadly higher; Israel Chemicals in focus
Mon, Nov 23 -
at MarketWatch | | • | TEVA | | Five Fast-Growing Stocks to Buy
Mon, Nov 23 -
at TheStreet.com | | | All Headlines for these symbols... |
|
|
|
1.48% Nasdaq 
Competitors
